All Articles

A new report reveals a dangerous disconnect: while AI accelerates coding, 95% of CISOs are pressured to ignore the security flaws it creates.

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

BioCardia secures a crucial $4.4M, extending its runway for a key Japan submission. But a closer look reveals a high-stakes bet on future warrant exercises.

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

Luxardo's new Decaf Espresso Liqueur isn't just a new bottle. It's a strategic move to capture the mindful drinking trend and dominate the espresso martini scene.

K-beauty leader Rael disrupts the U.S. market with advanced hydrogel masks and the first Korean-made tampon, pioneering a new era of 'K-Wellness'.

Good Grains' nationwide launch in Sprouts isn't just another product release. It's a signal of the food industry's pivot toward transparency and resilience.

A new alliance between tech firm Seequent and think tank Cascade Institute aims to map Canada's vast, untapped geothermal reserves using novel AI.

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

The promotion of Tony Pallas to CTO is no mere shuffle. It's a calculated move to arm thousands of franchisees with AI, signaling a new front in the war for hospitality tech dominance.

A tech firm with a history of pivots, Mitesco is launching an AI real estate tool. Can its unique strategy of deep industry collaboration overcome financial headwinds?

A Canadian upstart is poised to unlock a massive, untreated market by moving glaucoma surgery from the OR to the office. This isn't just a new device; it's a strategic dismantling of a decades-old bottleneck.

Eikon Therapeutics adds a consumer goods giant to its board, a move signaling a strategic pivot from pure science to global commercialization.

Amid market moderation, TerraCap's latest Florida acquisition highlights the enduring value of infill industrial assets and strategic capital improvements.

Truist's appointment of Lindsey Stampone isn't just a new hire; it's a calculated move to challenge rivals in the competitive PA & NJ banking markets.

After years of stabilization, a 90% stake in real estate firm DEMIRE is for sale. The move by Apollo and Wecken & Cie. could reshape the firm and signal a market shift.

A new R&D pact between ARCYN Defense and the U.S. Army isn't just a press release; it's a strategic maneuver in the multi-billion dollar C-UAS market.

Metropolitan Dermatology is the first in NJ to adopt Nevisense®, an AI-backed scanner for melanoma. Is this tech a true game-changer or one move in a complex market?